Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Humabs Biomed describes novel monoclonal antibody for treating hepatitis B virus infection

April 29, 2016

FDA extends PDUFA date for Heplisav-B BLA

April 28, 2016

Pneumococcal infection model reveals protective effects of B-cell epitopes

April 28, 2016

GlaxoSmithKline and Anacor Pharmaceuticals exploit novel mechanism for treating tuberculosis

April 28, 2016

Sun Pharma and partners establish malaria elimination demonstration project

April 27, 2016

hVIVO and SEEK in joint venture investment to develop vaccines against influenza and flu

April 27, 2016

AnGes and VIDO-InterVac collaborate to develop Ebola polyclonal antibody therapy

April 27, 2016

First-in-human results show potential of Ad26.ZEBOV and MVA-BN Filo Ebola vaccines

April 27, 2016

FDA approves AbbVie's sNDA for Viekira Pak

April 26, 2016

Cocrystal Pharma begins phase Ia/Ib study of HCV drug candidate

April 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.